filibuvir

Known as: (6R)-6-Cyclopentyl-6-(2-(2,6-Diethylpyridin-4-yl)Ethyl)-3-((5,7-Dimethyl(1,2,4)Triazolo(1,5- A)Pyrimidin-2-yl)Methyl)-4-Hydroxy-5,6-Dihydro-2H-Pyran-2-One, 2H-Pyran-2-One, 6-Cyclopentyl-6-(2-(2,6-Diethyl-4-Pyridinyl)Ethyl)-3-((5,7-Dimethyl(1,2,4)Triazolo(1,5-A)Pyrimidin-2-yl)Methyl)-5,6-Dihydro-4-Hydroxy-, (6R)- 
A non-nucleoside polymerase inhibitor of the hepatitis C virus NS5B RNA-dependent RNA polymerase. Filibuvir binds to the non-catalytic Thumb 2 site… (More)

Topic mentions per year

Topic mentions per year

2010-2017
012320102017

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2014
2014
UNLABELLED Hepatitis C virus (HCV) is a genetically diverse virus with multiple genotypes exhibiting remarkable differences… (More)
  • figure 1
  • table 3
  • figure 2
  • figure 3
  • figure 4
Is this relevant?
2014
2014
Direct-acting antivirals (DAAs) targeting proteins encoded by the hepatitis C virus (HCV) genome have great potential for the… (More)
  • figure 1
  • figure 2
  • table 1
  • figure 3
  • table 2
Is this relevant?
2013
2013
Development of allosteric inhibitors into efficient drugs is hampered by their indirect mode-of-action and complex structure… (More)
Is this relevant?
2013
2013
GS-9669 is a highly optimized thumb site II nonnucleoside inhibitor of the hepatitis C virus (HCV) RNA polymerase, with a binding… (More)
  • figure 1
  • table 1
  • table 3
  • table 2
  • table 4
Is this relevant?
2012
2012
Filibuvir (PF-00868554) is an investigational nonnucleoside inhibitor of the hepatitis C virus (HCV) nonstructural 5B (NS5B) RNA… (More)
Is this relevant?
2012
2012
Filibuvir and VX-222 are nonnucleoside inhibitors (NNIs) that bind to the thumb II allosteric pocket of the hepatitis C virus… (More)
  • figure 1
  • figure 2
  • figure 3
  • table 1
  • figure 5
Is this relevant?
2012
2012
The synthesis of filibuvir, a hepatitis C virus polymerase inhibitor candidate, involves use of 2,2,6,6-tetramethyl-1… (More)
Is this relevant?
2011
2011
UNLABELLED More effective and better-tolerated therapies are needed for chronic hepatitis C virus (HCV) infection. Among the… (More)
  • figure 1
  • table 1
  • figure 2
  • table 2
  • figure 3
Is this relevant?
2011
2011
The current standard of care for patients infected with hepatitis C virus (HCV) is not effective universally and is associated… (More)
Is this relevant?
Review
2010
Review
2010
Filibuvir (PF-868554), being developed by Pfizer, is an orally administered, non-nucleoside inhibitor of the HCV NS5B RNA… (More)
Is this relevant?